NEVRO CORP (NVRO) Stock Balance Sheet
USA - New York Stock Exchange - NYSE:NVRO - US64157F1030 - Common Stock
5.84 USD
0 (0%)
5.8401 USD
0 (0%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 94.54M | 104.22M | 120.40M | 34.70M | 44.60M | |||
| Marketable Securities | 198.00M | 218.51M | 254.00M | 327.30M | 543.40M | |||
| Receivables | 71.88M | 79.38M | 78.90M | 70.50M | 77.70M | |||
| Inventories | 103.27M | 118.68M | 99.60M | 93.50M | 83.30M | |||
| Other Current Assets | 8.32M | 10.14M | 10.00M | 5.20M | 4.20M | |||
| Total Current Assets | 476.00M | 530.92M | 562.90M | 531.20M | 753.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 47.75M | 33.51M | 35.70M | 38.20M | 31.70M | |||
| Goodwill | 0.00 | 38.16M | N/A | N/A | N/A | |||
| Intangibles | 24.41M | 27.35M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 5.68M | 5.76M | 3.80M | 5.10M | 4.60M | |||
| Total Non-Current Assets | 77.84M | 104.79M | 39.50M | 43.30M | 36.30M | |||
| TOTAL ASSETS | 553.84M | 635.71M | 602.40M | 574.50M | 789.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 37.97M | 0.00 | 0.00 | 0.00 | 168.80M | |||
| Accrued Expenses | 38.73M | 51.02M | 50.50M | 49.00M | 46.00M | |||
| Accounts Payable | 24.46M | 22.52M | 26.80M | 32.00M | 23.10M | |||
| Other Current Liabilities | 1.78M | 9.84M | 1.90M | 1.20M | 1.30M | |||
| Total Current Liabilities | 102.94M | 83.38M | 79.20M | 82.20M | 239.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 187.67M | 211.47M | 186.90M | 151.30M | 141.80M | |||
| Other Non-Current Liabilities | 32.22M | 47.72M | 12.50M | 37.40M | 20.00M | |||
| Total Non-Current Liabilities | 219.89M | 259.19M | 199.30M | 188.70M | 161.80M | |||
| TOTAL LIABILITIES | 322.83M | 342.57M | 278.50M | 270.90M | 401.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -812.85M | -699.41M | -607.20M | -624.20M | -492.80M | |||
| Additional Paid In Capital | 1.05B | 992.76M | 934.10M | 928.10M | 880.70M | |||
| Common Shares | 38.00K | 36.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -1.21M | -243.00K | -3.10M | -400.00K | 600.00K | |||
| Shares Outstanding | 37.82M | 36.36M | 35.50M | 35.70M | 34.60M | |||
| Tangible Book Value per Share | 5.46 | 6.26 | 9.12 | 8.50 | 11.23 | |||
| Total Shareholders' Equity | 231.01M | 293.14M | 323.90M | 303.60M | 388.50M | |||
| TOTAL LIABILITIES AND EQUITY | 553.84M | 635.71M | 602.40M | 574.50M | 789.40M | |||
| Statistics | ||||||||
| Debt/Equity | 0.98 | 0.72 | 0.58 | 0.50 | 0.80 | |||
| Current Ratio | 4.62 | 6.37 | 7.11 | 6.46 | 3.15 | |||
| Return On Assets (ROA) | -20.48% | -14.51% | 0.50% | -22.87% | -10.53% | |||
| Return On Equity (ROE) | -49.11% | -31.46% | 0.93% | -43.28% | -21.39% | |||
All data in USD , ROIC based on taxRate of 0.21